Company: IMCR
Filing Date: 2025-03-17
Form Type: 424B7
Source: 0001140361-25-008917
Chunk: 121

Company: Immunocore Holdings plc
Filing Date: 2025-03-17
Form: 424B7
Chunk 121
---
erees or other successors-in-interest selling notes or any note conversion ADSs received after the date of this prospectus supplement from the selling securityholders as a gift, pledge, partnership distribution or other transfer, may, from time to time, sell any or all of their notes or note conversion ADSs on any stock exchange, market or trading facility on which the notes or such note conversion ADSs are traded or in private transactions directly or through one or more broker dealers or agents. If the notes or note conversion ADSs are sold through broker-dealers, the selling securityholders will be responsible for discounts or commissions or agent’s commissions. Dispositions may be at fixed prices, at prevailing market prices at the time of sale, at prices related to the prevailing market price, at varying prices determined at the time of sale, or at negotiated prices. These sales may be effected in transactions which may involve crosses or block transactions. The selling securityholders may use any one or more of the following methods when disposing of shares or interests therein:

| • | ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers; |

| • | block trades in which the broker-dealer will attempt to sell the notes or note conversion ADSs as agent, but may position and resell a portion of the block as principal to facilitate the transaction; |

| • | purchases by a broker-dealer as principal and resale by the broker-dealer for its account; |

| • | an exchange distribution in accordance with the rules of the applicable exchange; |

| • | privately negotiated transactions; |

| • | short sales effected after the date of this prospectus supplement; |

| • | through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise; |

| • | broker-dealers may agree with the selling securityholders to sell a specified number of such shares at a stipulated price per share; |

| • | a combination of any such methods of sale; and |

| • | any other method permitted by applicable law. |

The selling securityholders may, from time to time, pledge or grant a security interest in some or all of the notes or note conversion ADSs owned by them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the notes or note conversion ADSs, from time to time, under this prospectus supplement, or under an amendment to this prospectus supplement under Rule 424(b)(3) or other applicable provision of the Securities